Disease Characteristics, Treatment Patterns and Clinical Outcomes in Patients With Newly Diagnosed Unresectable Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) in China
Status
Completed
Conditions
Non-Small Cell Lung Cancer, Lung Cancer, Cancer
Treatments
Other: No intervention
Details and patient eligibility
About
The purpose of this observational study is to describe patient and disease characteristics as well as treatment patterns in Chinese patients with unresectable stage IIIB or IV non-small cell lung cancer (NSCLC). In addition, this study characterizes the clinical outcomes for various populations of patients defined by clinical and tumor characteristics, treatment patterns, and hospital category defined by city tier and geographic region.
Enrollment
1,378 patients
Sex
All
Volunteers
No Healthy Volunteers
Inclusion criteria
- Histologically/cytologically confirmed, unresectable Stage IIIB or IV non-small cell lung cancer (NSCLC)
- Received at least one anti-cancer treatment targeting unresectable Stage IIIB or IV NSCLC in the study site after study initiation
- Radiographic evidence of disease
Exclusion criteria
- Prior systematic treatment for unresectable Stage IIIB or IV non-small cell lung cancer (NSCLC)
- Participation in any anti-cancer, regimen-specified clinical study of first-line treatment for unresectable Stage IIIB or IV NSCLC.
Trial design
1,378 participants in 6 patient groups
Tier 1 and North
Description:
Site as described by tier level of the city where the site is located and by geographical location: Tier 1 city in northern region of China
Treatment:
Other: No intervention
Tier 1 and South
Description:
Site as described by tier level of the city where the site is located and by geographical location: Tier 1 city in southern region of China
Treatment:
Other: No intervention
Tier 2 and Middle
Description:
Site as described by tier level of the city where the site is located and by geographical location: Tier city in middle region of China
Treatment:
Other: No intervention
Tier 2 and North
Description:
Site as described by tier level of the city where the site is located and by geographical location: Tier 2 city in northern region of China
Treatment:
Other: No intervention
Tier 2 and South Eastern
Description:
Site as described by tier level of the city where the site is located and by geographical location: Tier 2 city in south eastern region of China
Treatment:
Other: No intervention
Tier 2 and South Western
Description:
Site as described by tier level of the city where the site is located and by geographical location: Tier 2 city in south western region of China
Treatment:
Other: No intervention
Trial contacts and locations
11
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal
© Copyright 2024 Veeva Systems